Alzheimer’s disease market expected to reach $14.7bn across the 8MM by 2033

A major focus of R&D in the Alzheimer’s disease therapeutic space is preventing the accumulation of amyloid beta. A major focus of R&D in the Alzheimer’s disease therapeutic space is preventing the accumulation of amyloid beta. The Alzheimer’s disease market is projected to grow to $14.7bn by 2033. Credit: SkazovD / Shutterstock.com Unlock FREE Access to Premium Content ​Discover exclusive forecasts, analyst insights, and in-depth clinical trials industry analysis across drug development, clinical research, and trial innovation. With a free Clinical Trials Arena profile, you can: Experience unmatched clarity with a single platform that combines unique data, AI, and human…

Source: Clinical Trials Arena